GEODE CAPITAL MANAGEMENT, LLC - CONMED CORP ownership

CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 279 filers reported holding CONMED CORP in Q1 2022. The put-call ratio across all filers is 3.62 and the average weighting 0.1%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of CONMED CORP
ValueSharesWeighting
Q3 2023$61,869,144
-22.7%
613,397
+4.2%
0.01%
-22.2%
Q2 2023$79,990,877
+39.2%
588,644
+6.4%
0.01%
+28.6%
Q1 2023$57,453,207
+121972.0%
553,179
+4.2%
0.01%0.0%
Q4 2022$47,065
-99.9%
530,972
+3.6%
0.01%
+16.7%
Q3 2022$41,104,000
-11.7%
512,711
+5.5%
0.01%
-14.3%
Q2 2022$46,531,000
-36.5%
485,923
-1.4%
0.01%
-22.2%
Q1 2022$73,231,000
+8.1%
492,976
+3.2%
0.01%
+12.5%
Q4 2021$67,744,000
+11.3%
477,883
+2.7%
0.01%0.0%
Q3 2021$60,873,000
-6.5%
465,285
-1.8%
0.01%
-11.1%
Q2 2021$65,091,000
+12.8%
473,634
+7.2%
0.01%0.0%
Q1 2021$57,700,000
+25.9%
441,841
+8.0%
0.01%
+12.5%
Q4 2020$45,834,000
+52.0%
409,233
+6.8%
0.01%
+33.3%
Q3 2020$30,156,000
+6.1%
383,341
-2.9%
0.01%0.0%
Q2 2020$28,429,000
+28.6%
394,917
+2.3%
0.01%0.0%
Q1 2020$22,098,000
-74.1%
385,863
-49.5%
0.01%
-33.3%
Q4 2019$85,380,000
+136.5%
763,492
+103.4%
0.01%
+12.5%
Q3 2019$36,099,000
+13.1%
375,450
+0.7%
0.01%0.0%
Q2 2019$31,906,000
+16.0%
372,866
+12.7%
0.01%
+14.3%
Q1 2019$27,513,000
-27.8%
330,771
-44.3%
0.01%
+16.7%
Q4 2018$38,104,000
+76.9%
593,532
+118.3%
0.01%0.0%
Q3 2018$21,535,000
+12.6%
271,846
+4.0%
0.01%0.0%
Q2 2018$19,128,000
+27.5%
261,318
+10.3%
0.01%
+20.0%
Q1 2018$14,999,000
+27.2%
236,846
+2.3%
0.01%
+25.0%
Q4 2017$11,795,000
-1.9%
231,425
+1.0%
0.00%0.0%
Q3 2017$12,027,000
+5.3%
229,219
+2.2%
0.00%0.0%
Q2 2017$11,423,000
+21.6%
224,258
+6.0%
0.00%0.0%
Q1 2017$9,394,000
+9.8%
211,542
+9.2%
0.00%0.0%
Q4 2016$8,556,000
+14.0%
193,708
+3.4%
0.00%0.0%
Q3 2016$7,502,000
-14.5%
187,286
+1.8%
0.00%
-20.0%
Q2 2016$8,777,000
+15.4%
183,900
+1.4%
0.01%
+25.0%
Q1 2016$7,603,000
-2.9%
181,300
+2.0%
0.00%0.0%
Q4 2015$7,830,000
-8.3%
177,778
-0.6%
0.00%
-20.0%
Q3 2015$8,538,000
-15.9%
178,862
+2.6%
0.01%
-16.7%
Q2 2015$10,153,000
+19.9%
174,249
+3.9%
0.01%
+20.0%
Q1 2015$8,469,000
+22.6%
167,749
+9.2%
0.01%
+25.0%
Q4 2014$6,907,000
+23.6%
153,645
+1.3%
0.00%0.0%
Q3 2014$5,588,000
-12.4%
151,693
+5.0%
0.00%0.0%
Q2 2014$6,377,000
-3.0%
144,447
-4.6%
0.00%0.0%
Q1 2014$6,575,000
+4.3%
151,345
+2.1%
0.00%0.0%
Q4 2013$6,301,000
+25.0%
148,277
-0.0%
0.00%0.0%
Q3 2013$5,040,000
+10.0%
148,289
+1.1%
0.00%0.0%
Q2 2013$4,583,000146,7110.00%
Other shareholders
CONMED CORP shareholders Q1 2022
NameSharesValueWeighting ↓
SCOPIA CAPITAL MANAGEMENT LP 310,392$34,764,0004.40%
Iron Triangle Partners LP 148,317$16,612,0002.15%
Ranger Investment Management 294,664$33,002,0001.74%
Penn Capital Management Company, LLC 86,810$9,723,0001.23%
EARNEST PARTNERS LLC 1,575,336$176,438,0001.22%
Champlain Investment Partners, LLC 1,692,014$189,506,0001.09%
MOODY ALDRICH PARTNERS LLC 59,005$6,609,0001.07%
Hood River Capital Management LLC 232,412$26,030,0000.86%
OAK RIDGE INVESTMENTS LLC 80,775$9,047,0000.80%
Huber Capital Management LLC 18,620$2,085,0000.68%
View complete list of CONMED CORP shareholders